Issue 5, 2013

The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics

Abstract

Covering: up to the end of 2012

The Antibody Drug Conjugate (ADC) is a therapeutic modality consisting of a monoclonal antibody attached to a cytotoxic, small-molecule payload. The antibody portion of the ADC serves as a transport vehicle that recognizes and binds to a protein antigen expressed in tumor tissues. The localized delivery and release of the payload within or near malignant cells allows for targeted delivery of a potent cytotoxic agent to diseased tissue, while reducing damage to antigen-negative, normal tissues. Recent years have witnessed an explosive increase in ADC-based therapies, due mainly to clinical reports of activity in both hematologic and epithelial cancers. Accompanying this upsurge in ADC development is a renewed interest in natural product cytotoxins, which are typically highly potent cell-killing agents, but suffer from poor drug-like properties and narrow safety margins when systemically administered as conventional chemotherapeutics. In this review, we discuss recent advances related to the construction of ADCs, the optimization of ADC safety and efficacy, and the increasingly pivotal roles of natural product payloads in the current and future landscape of ADC therapy.

Graphical abstract: The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics

Article information

Article type
Review Article
Submitted
19 Nov 2012
First published
25 Mar 2013

Nat. Prod. Rep., 2013,30, 625-639

The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics

H. Gerber, F. E. Koehn and R. T. Abraham, Nat. Prod. Rep., 2013, 30, 625 DOI: 10.1039/C3NP20113A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements